• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根治性膀胱切除术和标准化扩大淋巴结清扫术后淋巴结阳性膀胱癌的癌症特异性生存:通过淋巴结阳性和密度进行预测

Cancer-specific survival after radical cystectomy and standardized extended lymphadenectomy for node-positive bladder cancer: prediction by lymph node positivity and density.

作者信息

Wiesner Christoph, Salzer Alice, Thomas Christian, Gellermann-Schultes Claudia, Gillitzer Rolf, Hampel Christian, Thüroff Joachim W

机构信息

Department of Urology, Johannes Gutenberg-University, Mainz, Germany.

出版信息

BJU Int. 2009 Aug;104(3):331-5. doi: 10.1111/j.1464-410X.2009.08403.x. Epub 2009 Feb 11.

DOI:10.1111/j.1464-410X.2009.08403.x
PMID:19220265
Abstract

OBJECTIVE

To investigate the associations between different overall or topographically restricted lymph node (LN) variables and cancer-specific survival (CSS) after radical cystectomy (RC) and extended LN dissection (LND) with curative intent in patients with LN-positive bladder cancer.

PATIENTS AND METHODS

Between 2001 and 2006, 152 patients had RC with standardized extended LND for bladder cancer with curative intent. Patients with positive LNs were stratified according to the median of the LN variables (LNs removed, number of positive LNs, LN density). CSS was related to overall and topographically restricted LN variables, e.g. different levels of LND, and relationships were tested by univariate and multivariate analyses. Level 1 LND comprised the regions of the external and internal iliac LNs and of the obturator LNs, level 2 the templates of common iliac and presacral LNs, and level 3 the para-aortic and paracaval LNs up to the inferior mesenteric artery. The mean (range) follow-up was 22 (1-84) months.

RESULTS

LN metastases were diagnosed in 46 of the 152 patients (30%) with extended LND. In these 46 patients, the median number of removed LNs was 33 (level 1, 15.5; level 2, 9.0; level 3, 7.0), the median number of positive LNs was 3 (1.5, 0.5 and 0.0, respectively) and the median LN density was 0.11 (0.10, 0.02 and 0.0, respectively). The CSS was 76% at 1 year and 23% at 3 years. There were significant correlations between the 3-year CSS and the overall LN density (< or =0.11 vs >0.11; 34% vs 8%, P = 0.008), and the total number of positive LNs (< or =3 vs >3; 33% vs 8%; P = 0.05). Overall LN density (hazard ratio 0.33, 95% confidence interval 0.15-0.72; P = 0.006) was an independent predictor for CSS in multivariate analysis. CONCLUSIONS Overall LN density is an independent predictor of survival after RC and extended LND with curative intent. Evaluation of topographically restricted LN positivity and density for different regions and levels of LND does not improve the prediction of CSS compared with overall LN positivity and density. A low incidence of level 3 LN positivity questions the clinical relevance of removing para-aortic and paracaval LNs. However, our data need to be confirmed by a prospective randomized trial.

摘要

目的

探讨在根治性膀胱切除术(RC)及扩大淋巴结清扫术(LND)且具有治愈目的的淋巴结阳性膀胱癌患者中,不同的总体或局部受限淋巴结(LN)变量与癌症特异性生存(CSS)之间的关联。

患者与方法

2001年至2006年间,152例患者接受了具有治愈目的的标准化扩大LND的RC治疗。LN阳性患者根据LN变量的中位数(切除的LN数量、阳性LN数量、LN密度)进行分层。CSS与总体和局部受限的LN变量相关,例如不同水平的LND,并通过单因素和多因素分析来检验两者之间的关系。第1级LND包括髂外和髂内淋巴结区域以及闭孔淋巴结区域,第2级包括髂总淋巴结和骶前淋巴结区域,第3级包括肠系膜下动脉水平以下的腹主动脉旁和腔静脉旁淋巴结。平均(范围)随访时间为22(1 - 84)个月。

结果

152例行扩大LND的患者中有46例(30%)诊断为LN转移。在这46例患者中,切除LN的中位数为33个(第1级,15.5个;第2级,9.0个;第3级,7.0个),阳性LN的中位数为3个(分别为1.5个、0.5个和0.0个),LN密度的中位数为0.11(分别为0.10、0.02和0.0)。CSS在1年时为76%,3年时为23%。3年CSS与总体LN密度(≤0.11 vs >0.11;34% vs 8%,P = 0.008)以及阳性LN总数(≤3 vs >3;33% vs 8%;P = 0.05)之间存在显著相关性。在多因素分析中,总体LN密度(风险比0.33,95%置信区间0.15 - 0.72;P = 0.006)是CSS的独立预测因素。结论总体LN密度是RC及具有治愈目的的扩大LND术后生存的独立预测因素。与总体LN阳性和密度相比,评估不同区域和水平LND的局部受限LN阳性和密度并不能改善CSS的预测。第3级LN阳性的低发生率质疑了切除腹主动脉旁和腔静脉旁淋巴结的临床相关性。然而,我们的数据需要通过前瞻性随机试验来证实。

相似文献

1
Cancer-specific survival after radical cystectomy and standardized extended lymphadenectomy for node-positive bladder cancer: prediction by lymph node positivity and density.根治性膀胱切除术和标准化扩大淋巴结清扫术后淋巴结阳性膀胱癌的癌症特异性生存:通过淋巴结阳性和密度进行预测
BJU Int. 2009 Aug;104(3):331-5. doi: 10.1111/j.1464-410X.2009.08403.x. Epub 2009 Feb 11.
2
Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.根治性膀胱切除术和扩大盆腔淋巴结清扫术:仅接受手术治疗的髂总血管分叉以上淋巴结转移患者的生存率。
J Urol. 2007 Oct;178(4 Pt 1):1218-23; discussion 1223-4. doi: 10.1016/j.juro.2007.05.160. Epub 2007 Aug 14.
3
Lymph node mapping in patients with bladder cancer undergoing radical cystectomy and lymph node dissection to the level of the inferior mesenteric artery.在接受根治性膀胱切除术和淋巴结清扫术至肠系膜下动脉水平的膀胱癌患者中进行淋巴结绘图。
BJU Int. 2010 Jul;106(2):199-205. doi: 10.1111/j.1464-410X.2009.09118.x. Epub 2009 Dec 9.
4
Role of lymph node density in predicting survival of patients with lymph node metastases after radical cystectomy: a multi-institutional study.淋巴结密度在预测根治性膀胱切除术后淋巴结转移患者生存率中的作用:一项多机构研究。
Int J Urol. 2009 Mar;16(3):274-8; discussion 278. doi: 10.1111/j.1442-2042.2008.02221.x. Epub 2008 Dec 12.
5
Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomy.在接受根治性膀胱切除术的淋巴结阴性膀胱癌患者中,盆腔淋巴结清扫术时解剖的淋巴结数量与癌症特异性生存的关系。
Ann Surg Oncol. 2011 Jul;18(7):2018-25. doi: 10.1245/s10434-010-1538-6. Epub 2011 Jan 19.
6
Lymph node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: a comparative mapping study.淋巴结清扫技术比淋巴结计数在根治性膀胱切除术中识别淋巴结转移更重要:一项比较映射研究。
Eur Urol. 2011 Nov;60(5):946-52. doi: 10.1016/j.eururo.2011.07.012. Epub 2011 Jul 14.
7
Evaluation of different lymph node (LN) variables as prognostic markers in patients undergoing radical cystectomy and extended LN dissection to the level of the inferior mesenteric artery.评估不同的淋巴结(LN)变量作为接受根治性膀胱切除术和扩展 LN 解剖至肠系膜下动脉水平的患者的预后标志物。
BJU Int. 2012 Feb;109(3):388-93. doi: 10.1111/j.1464-410X.2011.10369.x. Epub 2011 Aug 18.
8
The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy.接受根治性膀胱切除术的淋巴结转移患者中淋巴结清扫范围与生存之间的关联。
Cancer. 2008 Jun;112(11):2401-8. doi: 10.1002/cncr.23474.
9
Assessing the minimum number of lymph nodes needed at radical cystectomy in patients with bladder cancer.评估膀胱癌患者根治性膀胱切除术中所需的最少淋巴结数量。
BJU Int. 2009 May;103(10):1359-62. doi: 10.1111/j.1464-410X.2008.08212.x. Epub 2008 Dec 8.
10
Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy.根治性膀胱切除术后单一淋巴结转移患者的预后和相关因素。
BJU Int. 2013 Jan;111(1):74-84. doi: 10.1111/j.1464-410X.2012.11356.x. Epub 2012 Jul 19.

引用本文的文献

1
Ga-FAPI and F-FAPI PET/CT for detection of nodal metastases prior radical cystectomy in high-risk urothelial carcinoma patients.镓标记的纤维连接蛋白激活肽(Ga-FAPI)和氟标记的纤维连接蛋白激活肽(F-FAPI)PET/CT在高危尿路上皮癌患者根治性膀胱切除术前检测淋巴结转移中的应用
Eur J Nucl Med Mol Imaging. 2025 Apr 24. doi: 10.1007/s00259-025-07239-6.
2
2025 Canadian Urological Association Expert Report: Muscle-invasive bladder cancer.2025年加拿大泌尿外科学会专家报告:肌层浸润性膀胱癌
Can Urol Assoc J. 2025 Jan;19(1):E1-E16. doi: 10.5489/cuaj.9096.
3
Computed-tomography based scoring system predicts outcome for clinical lymph node-positive patients undergoing radical cystectomy.
基于计算机断层扫描的评分系统预测行根治性膀胱切除术的临床淋巴结阳性患者的结局。
Int Braz J Urol. 2022 Jan-Feb;48(1):89-98. doi: 10.1590/S1677-5538.IBJU.2021.0329.
4
Extranodal Extension Predicts Poor Survival Outcomes among Patients with Bladder Cancer.结外侵犯预示着膀胱癌患者的不良生存结局。
Cancers (Basel). 2021 Aug 15;13(16):4108. doi: 10.3390/cancers13164108.
5
Population-based outcome of muscle-invasive bladder cancer following radical cystectomy: who can benefit from adjuvant chemotherapy?根治性膀胱切除术后肌层浸润性膀胱癌的人群预后:谁能从辅助化疗中获益?
Transl Androl Urol. 2021 Jan;10(1):356-373. doi: 10.21037/tau-20-960.
6
Nomograms to predict individual prognosis of patients with squamous cell carcinoma of the urinary bladder.列线图预测膀胱鳞状细胞癌患者的个体预后。
BMC Cancer. 2019 Dec 9;19(1):1200. doi: 10.1186/s12885-019-6430-6.
7
Canadian Urological Association guideline: Muscle-invasive bladder cancer.加拿大泌尿外科协会指南:肌层浸润性膀胱癌
Can Urol Assoc J. 2019 Aug;13(8):230-238. doi: 10.5489/cuaj.5902.
8
Nomograms to Predict Individual Prognosis of Patients with Primary Small Cell Carcinoma of the Bladder.预测膀胱原发性小细胞癌患者个体预后的列线图
J Cancer. 2018 Mar 8;9(7):1152-1164. doi: 10.7150/jca.23344. eCollection 2018.
9
Oncologic Outcomes and Predictive Factors for Recurrence Following Robot-Assisted Radical Cystectomy for Urothelial Carcinoma: Multicenter Study from Korea.韩国多中心研究:机器人辅助根治性膀胱切除术治疗尿路上皮癌的肿瘤学结果和复发预测因素。
J Korean Med Sci. 2017 Oct;32(10):1662-1668. doi: 10.3346/jkms.2017.32.10.1662.
10
Lymph node density as a prognostic variable in node-positive bladder cancer: a meta-analysis.淋巴结密度作为淋巴结阳性膀胱癌的预后变量:一项荟萃分析。
BMC Cancer. 2015 Jun 2;15:447. doi: 10.1186/s12885-015-1448-x.